Home > Lectures > Malaria (I): The Case of Italy

Malaria (I): The Case of Italy

By Frank Snowden - Yale
get flash player

Lecture Description

Of all the diseases studied in this course, malaria has been responsible for the most human suffering. It has evolved alongside humans, and impacted human biology as well as civilization. In the former case, this impact is evident in genetic diseases like sickle-cell anemia which, while increasing vulnerability to a host of other illnesses, has the advantage of conferring substantial resistance to malaria. In social terms, malaria's debilitating sequelae have resulted in a reciprocal cycle of poverty and infection, low productivity and the desertion of profitable land weakening societies' ability to combat the disease and ultimately reinforcing a division between the global North (where malaria was eradicated following the Second World War) and the South, where the disease persists.

Course Description

Course Index

  1. Introduction to the Course
  2. Classical Views of Disease: Hippocrates, Galen, and Humoralism
  3. Plague (I): Pestilence as Disease
  4. Plague (II): Responses and Measures
  5. Plague (III): Illustrations and Conclusions
  6. Smallpox (I): 'The Speckled Monster'
  7. Smallpox (II): Jenner, Vaccination, and Eradication
  8. Nineteenth-Century Medicine: The Paris School of Medicine
  9. Asiatic Cholera (I): Personal Reflections
  10. Asiatic Cholera (II): Five Pandemics
  11. The Sanitary Movement and the 'Filth Theory of Disease'
  12. Syphilis: From the "Great Pox" to the Modern Version
  13. Contagionism versus Anticontagionism
  14. The Germ Theory of Disease
  15. Tropical Medicine as a Discipline
  16. Malaria (I): The Case of Italy
  17. Malaria (II): The Global Challenge
  18. Tuberculosis (I): The Era of Consumption
  19. Tuberculosis (II): After Robert Koch
  20. Pandemic Influenza
  21. The Tuskegee Experiment
  22. AIDS (I)
  23. AIDS (II)
  24. Poliomyelitis: Problems of Eradication
  25. SARS, Avian Inluenza, and Swine Flu: Lessons and Prospects
  26. Final Q&A